Pancreatic cancer trials in Italy
92 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 3RecruitingTrial-stage medicine
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Bari, Bologna, Florence, Meldola, Milan, Naples, Padova, Pavia, Pesaro, Pisa, Verona
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152EU 2026-525617-31-00Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Where
- Florence, Padova
- Age
- 18 years and over
- People
- 670 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07621718Registry updated 2026-11-06
No phaseRecruitingResearch participation
Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy
- Where
- Milan
- Age
- 18 years and over
- People
- 35
- Run by
- IRCCS San Raffaele
See details and how to joinNCT07095621Registry updated 2026-11-05
Phase 1RecruitingTrial-stage medicine
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Where
- Milan
- Age
- 18 years and over
- People
- 575 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06400472EU 2024-511238-11-00Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Where
- Milan, Reggio Emilia, Rome
- Age
- 18 years and over
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT06760819EU 2024-517419-62-00Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Bergamo, Milan, Naples, Perugia, Siena
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Bologna, Brescia, Milan, Naples, Siena, Verona
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075EU 2023-504853-11-00Registry updated 2026-11-03
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Where
- Bergamo, Brescia, Catania, Florence, Foggia, Genoa, Milan, Padova, Parma, Pisa, Ravenna, Reggio Emilia, Rome, Rozzano, Siena, Verona, Vicenza
- Age
- 18 years and over
- People
- 614 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07409272EU 2025-523684-38-00Registry updated 2026-11-03
Phase 2/3RecruitingTrial-stage medicine
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755EU 2025-521043-20-00Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma, Rome, Rozzano, Verona
- Age
- 18 years and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073Registry updated 2026-10-30
No phaseRecruitingResearch participation
Pancreatic Cancer Early Detection Consortium
- Where
- Verona
- Age
- 18 years to 90 years
- People
- 20,000 worldwide
- Run by
- Arbor Research Collaborative for Health
See details and how to joinNCT04970056Registry updated 2026-10-29
Phase 1/2RecruitingTrial-stage medicine
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
- Where
- Milan, Rome
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06428409EU 2023-508703-21-00Registry updated 2026-10-29
Phase 1/2RecruitingTrial-stage medicine
BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
- Where
- Milan, Naples, Pisa
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Bold Therapeutics, Inc.
See details and how to joinNCT04421820EU 2024-517500-11-00Registry updated 2026-10-28
Phase 1/2RecruitingTrial-stage medicine
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Aviano, Milan, Rome, Rozzano
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128EU 2025-520623-24-00Registry updated 2026-10-28
Phase 2RecruitingTrial-stage medicine
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Bergamo, Genova, Naples, Verona
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478EU 2023-507641-29-00Registry updated 2026-10-26
Phase 1/2RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Candiolo, Milan, Naples, Rome, Rozzano
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064EU 2023-509632-26-00Registry updated 2026-10-26
Phase 3RecruitingTrial-stage medicine
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Where
- Milan, Naples, Padova, Pisa, Rome, Verona
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07252232EU 2025-523495-23-00Registry updated 2026-10-23
Phase 3Not yet recruitingResearch participation
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Bologna, Florence, Foggia, Meldola, Milan, Modena, Naples, Padova, Pisa, Rome, Rozzano, Tricase, Verona
- Age
- 18 years and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00EU 2025-524969-24-00Registry updated 2026-10-20
No phaseNot yet recruitingResearch participation
Targeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Cancer
- Where
- Roma
- Age
- 18 years and over
- People
- 24
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT07883161Registry updated 2026-10-20
Phase 1/2RecruitingTrial-stage medicine
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Milan, Pisa, Roma
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034Registry updated 2026-10-19
Phase 2/3Not yet recruitingResearch participation
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination with Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants with First-Line Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Milan, Rozzano, Verona
- Age
- 18 years and over
- People
- 194 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-522563-15-00EU 2025-522563-15-00Registry updated 2026-10-16
Phase 1RecruitingTrial-stage medicine
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Bologna, Candiolo, Naples, Rozzano, Verona
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410EU 2024-513285-19-00Registry updated 2026-10-14
Phase 2/3RecruitingTrial-stage medicine
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Ancona, Florence, Foggia, Milan
- Age
- 18 years and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437EU 2025-522093-36-00Registry updated 2026-10-14
Phase 1/2Not yet recruitingResearch participation
SNIPER-LTFU: Long-term follow-up study of patients administered with RR001 in the interventional Parent SNIPER study
- Where
- Modena
- Age
- 18 years and over
- People
- 18
- Run by
- Eir Biotherapies S.r.l.
See details and how to join2026-525714-59-00EU 2026-525714-59-00Registry updated 2026-10-09
Phase 3RecruitingTrial-stage medicine
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Milan, Padova, Pisa, Rome, Rozzano, Tricase, Verona
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445EU 2025-525088-34-00Registry updated 2026-10-02
All Pancreatic cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.